![]() |
|
![]() |
|||||||||||||||||
![]() |
|
||||||||||||||||||
Richmont Holdings
Today's economy demands fresh thinking. Before the Great Recession, capital was easily available to innovative businesses. Entrepreneurs or companies simply raised capital and used it to buy whatever sales, marketing or operational support they needed. The capital market freeze changed everything. Many outstanding businesses can't gain traction in today's economic world. Our approach is more creative than solely investing capital. We invest at multiple levels. We look for interesting businesses in promising market sectors. When we find a venture that we believe has major potential, we invest in the form of capital or through the application of our own resources, or both. We have an experienced team with expertise in finance, operations, technology, sales, marketing and strategic business planning. We like to invest our intellectual capital in businesses that interest us. Businesses need strategic direction, sales and marketing support, financial analysis, technology and operations infrastructure. The Richmont team can provide such support as well. We are constantly approached about supporting various ventures, but we choose our partnerships carefully. We look for a good match with our own core values of integrity, entrepreneurship and social benefit. Richmont's portfolio includes a national provider of office imaging products and services to the public and private sectors which emphasizes environmentally-responsible supplies. It also includes TreeZero, producer of a new line of Earth-friendly, 100% treeless paper products, as well as the producer and seller of JavaFit, an innovative line of quality gourmet coffees which are infused with nutritional supplements to promote good health. One of Richmont's ventures, Richmont Sciences LLC., is the exclusive seller of a revolutionary, patented, EPA-registered disinfecting technology under the brand IV-7 Ultimate Germ DefenseTM. This product is effective against such deadly health threats as Influenza A, H1N1, Staph (including MRSA, the drug-resistant staph infection that plagues hospitals), norovirus, HIV Type 1, salmonella, E. coli and others. IV-7 uses the first new antimicrobial technology registered by the EPA in the past 35 years. Richmont's other investments include banking, publishing and technology. One Richmont investment, RealPage Inc., a software company whose product is used by nine of the ten largest property management companies in the United States, recently conducted a successful initial public offering and has a $1 billion market value. Over the past 25 years the Richmont partners have managed companies in such varied industries as finance, international trading, food service, personal care products, manufacturing, marketing and insurance. Richmont's chairman and founder is John P. Rochon. As founder and general partner of Richmont Capital Partners I, he led the partnership to become the largest shareholder in Avon Products Inc. Mr. Rochon served for years as chairman of Mary Kay Inc. and led its successful leveraged buyout and its subsequent global growth into a multi-billion dollar company. Other major investments have included RealPage Inc., Royal Appliance/Dirt Devil, Maybelline, The Dial Corp., Harvey's Hotels and Casinos, the Edison Project and Armor Holdings.
Richmont Holdings
2400 North Dallas Pkwy Suite 230 Dallas, TX 75093-4371 (972) 398-7100 |
|||||||||||||||||||
![]() |
© 2004 - 2005 Richmont Holdings, Inc. | ![]() |
|||||||||||||||||